258 related articles for article (PubMed ID: 32715672)
1. IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.
Song SK; Lee DH; Nam JH; Kim KT; Do JS; Kang DW; Kim SG; Cho MR
J Korean Med Sci; 2020 Jul; 35(29):e269. PubMed ID: 32715672
[TBL] [Abstract][Full Text] [Related]
2. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
[TBL] [Abstract][Full Text] [Related]
8. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
[TBL] [Abstract][Full Text] [Related]
9. Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France.
Mattern J; Vauloup-Fellous C; Zakaria H; Benachi A; Carrara J; Letourneau A; Bourgeois-Nicolaos N; De Luca D; Doucet-Populaire F; Vivanti AJ
PLoS One; 2020; 15(10):e0240782. PubMed ID: 33057392
[TBL] [Abstract][Full Text] [Related]
10. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR;
Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915
[TBL] [Abstract][Full Text] [Related]
11. Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing.
Takita M; Matsumura T; Yamamoto K; Yamashita E; Hosoda K; Hamaki T; Kusumi E
J Prim Care Community Health; 2020; 11():2150132720942695. PubMed ID: 32674696
[No Abstract] [Full Text] [Related]
12. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study.
Khan SMS; Qurieshi MA; Haq I; Majid S; Bhat AA; Nabi S; Ganai NA; Zahoor N; Nisar A; Chowdri IN; Qazi TB; Kousar R; Lone AA; Sabah I; Nabi S; Sumji IA; Kawoosa MF; Ayoub S
PLoS One; 2020; 15(11):e0239303. PubMed ID: 33175878
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.
Fischer B; Knabbe C; Vollmer T
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700672
[TBL] [Abstract][Full Text] [Related]
16. Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.
Das MK; Chaudhary A; Bryan A; Wener MH; Fink SL; Morishima C
Emerg Infect Dis; 2020 Oct; 26(10):2501-2503. PubMed ID: 32723430
[TBL] [Abstract][Full Text] [Related]
17. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
Choe PG; Kang CK; Suh HJ; Jung J; Kang E; Lee SY; Song KH; Kim HB; Kim NJ; Park WB; Kim ES; Oh MD
Emerg Infect Dis; 2020 Oct; 26(10):2484-2487. PubMed ID: 32579877
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
Clarke C; Prendecki M; Dhutia A; Ali MA; Sajjad H; Shivakumar O; Lightstone L; Kelleher P; Pickering MC; Thomas D; Charif R; Griffith M; McAdoo SP; Willicombe M
J Am Soc Nephrol; 2020 Sep; 31(9):1969-1975. PubMed ID: 32732391
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.
Xu X; Sun J; Nie S; Li H; Kong Y; Liang M; Hou J; Huang X; Li D; Ma T; Peng J; Gao S; Shao Y; Zhu H; Lau JY; Wang G; Xie C; Jiang L; Huang A; Yang Z; Zhang K; Hou FF
Nat Med; 2020 Aug; 26(8):1193-1195. PubMed ID: 32504052
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
